As the mTOR axis is regulated by upstream PI3K/AKT signals, which are aberrantly active in several solid tumors, enhanced mTOR activity is also found in those patients, creating a promising cancer therapeutic target [69,71,84,85,86]. The gene discussed is MTOR; the disease is cancer.